On the Active Site Protonation State in Aspartic Proteases: Implications for Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|23|4257-4275

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.23, 2013-07, pp. : 4257-4275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspartic Proteases in Drug Discovery

By  

Current Pharmaceutical Design, Vol. 13, Iss. 3, 2007-01 ,pp. : 271-285

Bentham Science Publishers

Access to resources Recommend Favorite

Viral Proteases as Targets for Drug Design

By  

Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. : 1126-1153

Bentham Science Publishers

Access to resources Recommend Favorite

The Derivation of a Potential Transition-State for the Reduction Reaction Catalysed by 17&bgr; -Hydroxysteroid Dehydrogenase Type 3 (17&bgr; -HSD) - An Approximate Representation of its Active Site for Use in Drug Design and Discovery

By  

Letters in Drug Design & Discovery, Vol. 4, Iss. 7, 2007-01 ,pp. : 527-531

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Design For Flavivirus Proteases: What Are We Missing?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 21, 2014-05 ,pp. : 3422-3427

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of aspartic proteases – potential antimalarial agents

By Boss Christoph   Corminboeuf Olivier   Grisostomi Corinna   Weller Thomas  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 295-317

Informa Healthcare

Access to resources Recommend Favorite